Stories

The World Health Organization commemorated the 20th anniversary of the Framework Convention on Tobacco Control (FCTC), the global health treaty with 182 member countries. Despite high ambitions, the FCTC has not significantly reduced smoking rates worldwide. The WHO's focus on nicotine, rather than harm reduction, has hindered progress, leading to secrecy in decision-making and the exclusion of alternative voices. The treaty rejects innovative harm reduction strategies like non-combustible nicotine products, despite evidence of their benefits. The WHO's anti-vaping stance, based on outdated views, has deprived millions of smokers of safer alternatives. A modernized approach, embracing harm reduction, is needed for effective global tobacco control.

The update to the EU's Tobacco Excise Tax Directive seeks harm reduction through taxing safer products less, potentially reducing smoking rates and illicit markets. Sweden's success in embracing alternative tobacco products and reducing smoking rates is a model for other EU countries to follow. ATPs like vaping and snus offer less harmful nicotine consumption options, driving public health benefits globally. However, stringent restrictions in some EU countries hinder harm reduction. An updated Directive should support less harmful products through reduced taxes, promoting public health. International businesses could shift focus to safer products, influencing global health trends positively. The EU must lead by example in harm reduction for tobacco policy worldwide.

Smoking rates are increasing in some parts of England for the first time in nearly two decades, prompting calls for more investment in tobacco control. Higher tobacco taxes have led to a thriving black market, making smoking more affordable. Public misconception about vaping's harm versus smoking's poses a challenge. The looming tobacco and vape regulations may drive a resurgence in smoking, particularly among younger generations. The appeal of the forbidden fruit and influencers glamorizing smoking could play a role. The government's upcoming restrictions on vaping could further fuel this trend, potentially reversing anti-smoking efforts.

The EU faces pressure from anti-vaping advocates to impose strict regulations on e-cigarettes. The Dutch Health Minister urged the EU to take decisive action, including flavor restrictions. Various EU countries are adopting their own vaping regulations, with a trend towards flavor bans. However, studies show flavor bans may increase harm by driving consumers to the black market. Lessons from regions like the US, Canada, and Australia demonstrate the unintended consequences of flavor bans. To achieve harm reduction goals, the EU should adopt a balanced vaping policy that supports smokers in transitioning away from tobacco. Embracing harm reduction strategies, like those in Sweden and Norway, can lead to a successful tobacco-free future.

E-cigarette companies like British American Tobacco lobbied to loosen vape regulations in NZ and Australia. They argue vaping is replacing smoking based on a 2020 study. However, a new study found vaping slowed the decline in youth smoking rates since 2010. The 2020 study didn't consider this and influenced policy decisions. Research suggests vaping may lead to smoking uptake in NZ adolescents, emphasizing the need for comprehensive policies addressing both vaping and smoking. Policymakers globally should be cautious of unintended consequences on youth when crafting regulations around vaping products for adults.

Smoking rates in parts of England have recently risen after nearly two decades of decline. Research from University College London showed a 10% increase in smoking in southern England from 2020 to 2024. The study suggested higher smoking rates among women and potential relapses among quitters. Despite progress in the north, concerns about funding cuts for smoking cessation programs were raised. Efforts to tackle smoking are seen as crucial, with calls for equal access to stop smoking services across the country. Experts emphasize the importance of maintaining momentum to achieve a smoke-free UK.

Multiple European countries are imposing bans and restrictions on nicotine pouches, while combustible cigarettes remain unrestricted. Tobacco control groups claim nicotine pouches are a ploy by the tobacco industry to hook young users. Despite being safer than smoking, pouches face scrutiny. The European Union lacks specific regulations for pouches, leading to member states creating disparate laws. Some countries, like Belgium, France, and the Netherlands, have banned pouch sales, while others implement limits on nicotine strength and flavors. The EU's failure to address pouch regulation contrasts with widespread cigarette availability, undermining harm reduction efforts and public health benefits.

UCLA-led research suggests electronic cigarettes may pose lower cardiovascular risks for those living with HIV compared to tobacco cigarettes. People with HIV smoke at higher rates, facing tobacco-related health disparities. Conducted with a novel laboratory model, the study found e-cigarettes are less likely to cause atherogenesis, a key factor in artery blockages. Dr. Middlekauff recommends switching to e-cigarettes as a harm reduction strategy; tobacco smoking is a leading cause of preventable cardiovascular death in the U.S. Larger clinical trials are needed to confirm these findings. This data could help reduce heart attack risks for people living with HIV.

The Canadian Cancer Society launched a vaping cessation program for young adults in Quebec, aiming to help combat the health risks associated with vaping. The program, titled “Aspire à mieux,” offers tailored support to help young people quit vaping, as 22% of those aged 18 to 24 in Quebec use vaping products. The initiative includes personalized text messaging, a mobile app, and peer support groups. With concerns over misinformation about the safety of vaping, the program provides accessible resources and assistance. The success of the pilot program led to its expansion to the general public.

Nicotine dependency is a tough habit to break, impacting both brain reward systems and physical routines. CBD is gaining attention as a non-addictive alternative due to its interaction with brain receptors that regulate cravings and stress. Canavape, founded in 2014, offers a variety of CBD products aimed at providing well-being support. CBD's effectiveness is attributed to its interaction with the endocannabinoid system, different from nicotine's action on acetylcholine receptors. Canavape products are UK-formulated and lab-tested, catering to diverse well-being needs. For those looking to transition from nicotine, CBD provides a holistic solution supporting physical and mental health.